CellCentric expands presence at Chesterford Research Park
Chesterford Research Park has announced the expansion of existing occupier, CellCentric, within the Mansion House at the heart of the Park. The clinical stage biotechnology company focused on the development of a novel drug for specific cancers has renewed its current...
Energy storage and R&D company Superdielectrics expands at Chesterford Research Park
Chesterford Research Park has announced the expansion of an existing occupier, SuperDielectrics, into new laboratory and write up space within the Emmanuel Building. Superdielectrics first moved to Chesterford Research Park in February this year, taking a suite...
Microbiotica moves into new building at Chesterford Research Park
Microbiotica, a leading player in microbiome-based therapeutics and biomarkers has announced it has finalised its move to purpose-configured facilities at Chesterford Research Park, to accommodate its long-term growth requirements. The Company’s operations were...
Oncologica is the first UK genomic testing lab to be Government approved for day 2 and day 8 testing
Chesterford Research Park based Oncologica, a leading cancer medicine and Covid-19 genomic sequencing laboratory is pleased to announce that its Cambridge based testing laboratory is now the first UK laboratory to receive approval by UKAS and the Department of Health...
Synthetic biology company, Camena Bioscience, expands presence at Chesterford Research Park
Chesterford Research Park is delighted to confirm the expansion of Camena Bioscience within the Science Village Building at the Park. The developer of an industry-leading DNA synthesis technology has renewed its existing lease for a further five years and in tandem...
